Status:
RECRUITING
Primary Aldosteronism: Prospective Screening Registry in China
Lead Sponsor:
Shanghai Jiao Tong University School of Medicine
Conditions:
Primary Aldosteronism
Eligibility:
All Genders
18-65 years
Brief Summary
1. Study name: A prospective study of the incidence and outcomes of Primary aldosteronism in Chinese hypertensive patients 2. Rationale: Unlike essential hypertension, secondary hypertension is caused...
Detailed Description
1. Study name: A prospective study of the incidence and outcomes of Primary aldosteronism in Chinese hypertensive patients 2. Rationale: Hypertension is the most common cardiovascular disease, a serio...
Eligibility Criteria
Inclusion
- Eligibility criteria
- Age: more than or equal to 18 years old;
- Hypertensive patients ;
- ARR \> 40;
- Informed consent;
- Exclusion criteria:
- Not eligible for inclusion or in situations considered unqualified for the study by the investigator.
Exclusion
Key Trial Info
Start Date :
July 18 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT04020783
Start Date
July 18 2018
End Date
December 1 2024
Last Update
August 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Institite of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, China, 200025